TY - JOUR
T1 - Ocular manifestations and outcomes of OPMD- a report from the national IsrOPMD registry
AU - Mekiten, Ori
AU - Zvulunov, Alex
AU - Ben Simon, Guy
AU - Charas, Hagit
AU - Ben-David, Merav
AU - Shelly, Shahar
AU - Greenbaum, Lior
AU - Dori, Amir
AU - Benyamini, Limor
AU - Zur, Dinah
AU - Levi, Niv
AU - Landau Prat, Daphna
AU - Zloto, Ofira
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2025/3
Y1 - 2025/3
N2 - Purpose: This study aims to describe the ocular manifestations, treatment, and prognosis of OPMD patients registered in the national Israel OPMD(IsrOPMD) registry. Methods: Data was prospectively collected from patients referred to the IsrOPMD registry from January 2022 to March 2023. This included patient demographics, medical and ocular history, eye exams, eyelid evaluations, visual field exams, and orthoptic evaluations. Results: 30 patients (15 males, mean age 53 years) were treated in the ocular OPMD clinic, predominantly of Bukhari descent (86.6%). The mean visual acuity was 0.06 logMAR. Twenty-one patients (70%) had eye movement problem, mostly in horizontal gaze. 6(20%) patients’ complaint about diplopia. Ptosis surgery was performed in 21(70%) patients, with 17(56.7%) patients underwent frontalis sling surgery and 4(13.3%) patients undergoing levator advancement. The mean Margin reflex distance (MRD1) improved post-surgery (2.28 mm vs. 1.58 mm), but 11(36.6%) patients required more than one ptosis surgery. Conclusions: The study contributes valuable insights into the ocular aspects of OPMD. It reveals that OPMD patients often experience a range of ocular symptoms, such as ptosis, abnormalities in eye movements, strabismus, and potentially diplopia, which can significantly impact their quality of life. The findings underscore the importance of regular ophthalmological follow-up for these patients to address these symptoms effectively. The study is significant in contributing to the limited but growing knowledge about the ocular manifestations of OPMD and the management of these symptoms to improve the quality of life for patients suffering from this condition.
AB - Purpose: This study aims to describe the ocular manifestations, treatment, and prognosis of OPMD patients registered in the national Israel OPMD(IsrOPMD) registry. Methods: Data was prospectively collected from patients referred to the IsrOPMD registry from January 2022 to March 2023. This included patient demographics, medical and ocular history, eye exams, eyelid evaluations, visual field exams, and orthoptic evaluations. Results: 30 patients (15 males, mean age 53 years) were treated in the ocular OPMD clinic, predominantly of Bukhari descent (86.6%). The mean visual acuity was 0.06 logMAR. Twenty-one patients (70%) had eye movement problem, mostly in horizontal gaze. 6(20%) patients’ complaint about diplopia. Ptosis surgery was performed in 21(70%) patients, with 17(56.7%) patients underwent frontalis sling surgery and 4(13.3%) patients undergoing levator advancement. The mean Margin reflex distance (MRD1) improved post-surgery (2.28 mm vs. 1.58 mm), but 11(36.6%) patients required more than one ptosis surgery. Conclusions: The study contributes valuable insights into the ocular aspects of OPMD. It reveals that OPMD patients often experience a range of ocular symptoms, such as ptosis, abnormalities in eye movements, strabismus, and potentially diplopia, which can significantly impact their quality of life. The findings underscore the importance of regular ophthalmological follow-up for these patients to address these symptoms effectively. The study is significant in contributing to the limited but growing knowledge about the ocular manifestations of OPMD and the management of these symptoms to improve the quality of life for patients suffering from this condition.
KW - Eyelid disease: eyelid malpositions/Trichiasis/Ptosis < OCULOPLASTIC EYELID /LACRIMAL DISEASE
KW - STRABISMUS
KW - eye movement disorders < STRABISMUS
KW - eyelid disease < OCULOPLASTIC EYELID /LACRIMAL DISEASE
KW - genetics < GENETICS
UR - http://www.scopus.com/inward/record.url?scp=85195140527&partnerID=8YFLogxK
U2 - 10.1177/11206721241259145
DO - 10.1177/11206721241259145
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 38809679
AN - SCOPUS:85195140527
SN - 1120-6721
VL - 35
SP - 451
EP - 455
JO - European Journal of Ophthalmology
JF - European Journal of Ophthalmology
IS - 2
ER -